These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4050164)

  • 1. Absorption of calcium, magnesium and phosphate during chronic renal failure and the effect of vitamin D in rabbits.
    Tvedegaard E
    Z Versuchstierkd; 1985; 27(3-4):163-8. PubMed ID: 4050164
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients.
    Peacock M; Davison AM; Walker GS
    Adv Exp Med Biol; 1977; 81():559-69. PubMed ID: 899940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
    Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnesium metabolism in the rat with chronic renal failure.
    Kaye M
    J Lab Clin Med; 1974 Oct; 84(4):536-45. PubMed ID: 4414542
    [No Abstract]   [Full Text] [Related]  

  • 6. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnesium, calcium and phosphates in plasma and urine in chronic renal failure in a case of nephrocalcinosis with congenital renal malformations].
    Halikowski B; Kucharska K; Tarnawska T; Sikorska B
    Pediatr Pol; 1969 Aug; 44(8):1019-24. PubMed ID: 5824743
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma 1,25 hydroxycholecalciferol concentrations and net intestinal calcium, phosphate and magnesium absorption in man.
    Ruggiero M; Brunese M; Morelli S; Salvia PF; Mangoni C; Stefano S
    Boll Soc Ital Biol Sper; 1981 Apr; 57(7):791-7. PubMed ID: 6895034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure and magnesium metabolism.
    Lindeman RD
    Magnesium; 1986; 5(5-6):293-300. PubMed ID: 3807422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal handling of calcium, magnesium and inorganic phosphate in chronic renal failure.
    Better OS; Kleeman CR; Gonick HC; Varrady PD; Maxwell MH
    Isr J Med Sci; 1967; 3(1):60-79. PubMed ID: 6047692
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency.
    Davis GR; Zerwekh JE; Parker TF; Krejs GJ; Pak CY; Fordtran JS
    Gastroenterology; 1983 Oct; 85(4):908-16. PubMed ID: 6688402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 1-alpha-hydroxycholecalciferol (1 alpha-OH/D3) and 24,25-dihydroxycholecalciferol (24, 25-OH)2D3) on calcium and phosphorus metabolism in chronic renal failure].
    Galus K; Szymendera J; Jelińska S; Schabowska M; Jelonek A
    Pol Arch Med Wewn; 1979 Feb; 61(2):105-12. PubMed ID: 440977
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 1-alpha-hydroxycholecalciferol on magnesium metabolism in chronic renal failure.
    Kanis JA; Smith R; Walton RJ; Bartlett M
    Br Med J; 1977 Jan; 1(6055):211. PubMed ID: 832080
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 1alpha-hydroxyvitamin D3 in patients with chronic renal failure, with particular emphasis on the renal handling of phosphate.
    Madsen S; Olgaard K
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():85s-89s. PubMed ID: 606430
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 1 alpha-hydroxyvitamin D3 and dietary calcium and phosphate on the aortic mineral content in rabbits with mild azotemia.
    Tvedegaard E; Ladefoged O; Nielsen M; Kamstrup O
    Nephron; 1983; 34(3):185-91. PubMed ID: 6877450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 25-hydroxycholecalciferol on calcium metabolism in chronic renal failure.
    Letteri JM; Kleinman LM; Ellis KN; Caselnova R; Akhtar M; Cohn SH
    Adv Exp Med Biol; 1977; 81():591-601. PubMed ID: 899943
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 20. Action of vitamin D metabolites in humans.
    Rasmussen H; Bordier P; Marie P; Miravet L; Ryckwaert A
    Trans Assoc Am Physicians; 1977; 90():380-9. PubMed ID: 611668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.